Our Team
A Team Built to Deliver What Matters Most
DLR Pharma is powered by a collective of industry veterans, each bringing deep expertise and a shared passion for transforming healthcare. From business development and licensing, to clinical development, market access, pricing, and commercialization—we bring together the expertise needed to navigate one of the world’s most complex healthcare markets.
Commercial Strategy
Shoji Kuroyama
Executive Advisor
President and representative director of Recordati Rare Diseases Japan KK, previously with Incyte and J&J
Yoshio Umeda
Advisor
CEO of Seed Planning, well-known marketing research company
Kiyoyoshi Matsubara
Advisor
President, Office Medisearch
Clinical Development
Aurora Clinical
Partner for regulatory strategy and trial execution in Japan
Finance
Kiichiro Kawada
External Director
Legal, IP & Accounting
Masahiko Kato
Legal
Previously Boehringer Ingelheim, ActualEyes
Takeshi Komatani
Advisor
Takashima International Patent Office
Hiroyuki Goto
Accounting
Previously Venture Support, ActualEyes
Business Development & Licensing
Johan Westblad
Member of the Board
Previously IQVIA Japan, Invest Sweden Agency
Simon Tsang
Advisor
Iku Sugioka
President & CEO
This collective experience gives our partners confidence: when you work with DLR Pharma, your innovation is in the hands of people who know how to deliver results.